The Clinical Intelligence Your Hardware Is Missing
Hardware companies have mastered the ear. They have not solved tinnitus. The clinical logic that turns sound into measurable neural change is a separate discipline — and it is licensable. Neuromonics partners with manufacturers to embed FDA-cleared, peer-reviewed treatment intelligence directly into hearables, hearing aids, and wearable platforms.
Hardware Exists in Every Ear. Clinical Logic Does Not.
The global hearables ecosystem will exceed $93B by 2030. The clinical tinnitus market alone is projected at over $5B. Yet 740 million people worldwide live with tinnitus, and 83% of them never receive an effective intervention. The bottleneck is not hardware — it is the absence of validated, prescriptive treatment logic running on the hardware they already wear.
The Algorithm
Two decades of peer-reviewed neuroscience, eleven independent clinical trials, and FDA 510(k) clearance underpin the Neuromonics treatment algorithm. It is not a sound generator. It is a closed-loop neuromodulation engine — adaptive spectral shaping driven by a patient's audiometric profile, calibrated to engage limbic and auditory cortex pathways simultaneously. The result is durable habituation, not symptomatic masking.
Three Ways to Integrate
Who This Is For
Licensing partners typically share one trait: hardware that already lives in or near the ear, and a roadmap that needs clinical defensibility to move beyond consumer features into reimbursable, recommendable health technology.
The Clinical Foundation
Neuromonics is not a research-stage hypothesis. It is a deployed, peer-reviewed, FDA-cleared therapy with two decades of clinical record across thousands of patients and dozens of independent investigators. Licensing partners inherit that evidence base on day one.
Partners receive full clinical, regulatory, and engineering support: integration documentation, calibration tools, regulatory dossiers, ongoing algorithm refinement, and a dedicated clinical liaison for trial design and outcomes reporting.
Neural Hygiene as a Service
The future of hearable revenue is not the device — it is the recurring clinical service running on the device. Tinnitus is the first indication. The same neuromodulation framework extends to hyperacusis, auditory processing, and sleep-onset insomnia. Licensing the algorithm today positions your platform for a category of subscription, prescription, and reimbursement revenue that hardware margins alone cannot reach.
Sound Vitamins
Our proprietary algorithms modify music to account for individual hearing profiles, providing targeted stimulation to the auditory system that promotes neurological desensitization.